Darzalex Faspro

Daratumumab,

Hyaluronidase-Fihj

5.0 Moderate risk

Darzalex Faspro & Product dose omission issue

24.6%

of users reported Product dose omission issue

100.0%

also reported Severe reaction

51.2%

are women

Most common medical consequences

Severe reaction

100.0%

Have you experienced any negative side effects from this medication?

Darzalex Faspro: general information

Most common side effects (13)

Most commonly affected ages

60 - 69 years

34.5%

70 - 79 years

65.5%

On this page